CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients : a HuGEnet systematic review and meta-analysis

S. Sanderson, Jon Emery, J. Higgins

    Research output: Contribution to journalArticle

    321 Citations (Scopus)

    Fingerprint Dive into the research topics of 'CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients : a HuGEnet systematic review and meta-analysis'. Together they form a unique fingerprint.

    Medicine & Life Sciences